Adjuvant therapy with high dose vitamin D following primary treatment of melanoma at high risk of recurrence: A placebo controlled randomised phase II trial (ANZMTG 02.09 Mel-D)
Robyn P.M. Saw, Bruce K. Armstrong, Rebecca S. Mason, Rachael L. Morton, Kerwin F. Shannon, Andrew J. Spillane, Jonathan R. Stretch, John F. Thompson
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Adjuvant therapy with high dose vitamin D following primary treatment of melanoma at high risk of recurrence: A placebo controlled randomised phase II trial (ANZMTG 02.09 Mel-D)'. Together they form a unique fingerprint.